Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China · Delayed Price · Currency is CNY 26.49
-0.10 (-0.38%)
Aug 15, 2025, 2:45 PM CST
SHA:600566 Revenue
Hubei Jumpcan Pharmaceutical had revenue of 1.53B CNY in the quarter ending March 31, 2025, a decrease of -36.51%. This brings the company's revenue in the last twelve months to 7.14B, down -26.16% year-over-year. In the year 2024, Hubei Jumpcan Pharmaceutical had annual revenue of 8.02B, down -16.96%.
Revenue (ttm)
7.14B
Revenue Growth
-26.16%
P/S Ratio
3.42
Revenue / Employee
1.42M
Employees
5,026
Market Cap
24.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 8.02B | -1.64B | -16.96% |
| Dec 31, 2023 | 9.65B | 658.17M | 7.32% |
| Dec 31, 2022 | 9.00B | 1.37B | 17.90% |
| Dec 31, 2021 | 7.63B | 1.47B | 23.77% |
| Dec 31, 2020 | 6.16B | -775.02M | -11.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| WuXi AppTec | 41.48B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |